Deb Keller recently retired after a notable life sciences career at Covance Drug Development, culminating as its CEO. Responsible for over $3 billion in revenue, and 12,000 employees in 100 countries, Deb led the company through its acquisition by Labcorp, where she served on the executive leadership team, reporting to Labcorp’s Chairman and CEO. Deb was named one of FierceBiotech’s 10 Top Women in Biotech 2012.